日本語
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#formycon 検索結果

doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
2025/02/21

$TEVA and #Alvotech Announce SELARSDI (ustekinumab-aekn) Injection Now Available in the U.S. #Formycon $FYB #Biosimilars globenewswire.com/news-release/2…

0
0
0
0
601
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
2025/02/18

$REGN and $FYB #Formycon relevant: #Alvotech and $TEVA Announce Filing Acceptance of U.S. BLA for AVT06, a Proposed Biosimilar to #Eylea (aflibercept). The process to obtain regulatory approval is anticipated to be completed in the fourth quarter of 2025. globenewswire.com/news-release/2…

0
0
1
0
857
CNBCTV18News's profile picture. Follow business news with India's Leading Business News Channel, CNBC-TV18. For more updates, follow @CNBCTV18Live. YouTube: https://t.co/8QufJyJ9c9
CNBC-TV18
@CNBCTV18News
/12/09

#Zydus Life unit partners with #Formycon to supply immunotherapy drug Keytruda biosimilar in US, Canada #ZydusLifesciences @jpullokaran buff.ly/oohK5is

CNBCTV18News's tweet image. #Zydus Life unit partners with #Formycon to supply immunotherapy drug Keytruda biosimilar in US, Canada #ZydusLifesciences @jpullokaran buff.ly/oohK5is
2
3
7
1
2千
Papamicha007's profile picture. Hier Privat. #Vermögensverwaltung, #Kapitalmarkt, #Aktien insb. aus #Süddeutschland, Musik, #VfB, und was sonst noch Interessant ist 😎 #thinkglobalinvestlocal
Michael Mayer
 @Papamicha007
2024/01/29

Neuer #Investor! - #Formycon beschließt Barkapitalerhöhung in Höhe von 82,84 Mio. €, sämtliche neuen Aktien werden vom ungarischen multinationalen #Spezialpharmaunternehmen #GedeonRichter als neuem strategischen Investor gezeichnet - nachbörslich +3.5% - eqs-news.com/de/news/adhoc/…

1
0
2
0
343
aktionaer's profile picture. Schnell, detailliert, auf den Punkt. DER AKTIONÄR, Deutschlands führendes Börsenmagazin https://t.co/kQjwV0Mdeu
DER AKTIONÄR
@aktionaer
2025/02/17

#Formycon kündigt massive Abschreibungen wegen Preisdruck an und pausiert US-Vertrieb eines Biosimilars.🚨 deraktionaer.de/artikel/pharma…

aktionaer's tweet card. Formycon kündigt massive Abschreibungen wegen Preisdruck an und pausiert US-Vertrieb eines Biosimilars.
Formycon-Aktie crasht: Die Hintergründe!
ソース: deraktionaer.de
0
0
2
0
2千
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
/02/05

$FYB #Formycon FYB206 – #Keytruda #Biosimilar candidate Top Line Data expected in Q1/2026. $MRK deraktionaer.de/artikel/pharma…

doepke_michel's tweet image. $FYB #Formycon FYB206 – #Keytruda #Biosimilar candidate Top Line Data expected in Q1/2026. $MRK deraktionaer.de/artikel/pharma…
0
0
9
0
1千
aktionaer's profile picture. Schnell, detailliert, auf den Punkt. DER AKTIONÄR, Deutschlands führendes Börsenmagazin https://t.co/kQjwV0Mdeu
DER AKTIONÄR
@aktionaer
2025/02/20

#Formycon-Aktie stürzt nach Abschreibungsankündigung ab - Daten zu Stelara-Biosimilar FYB202 werden bei ECCO präsentiert. deraktionaer.de/artikel/pharma…

aktionaer's tweet card. Formycon-Aktie stürzt nach Abschreibungsankündigung ab; Daten zu Stelara-Biosimilar FYB202 werden bei ECCO präsentiert.
Formycon nach dem Crash: Datenvorlage – Kursziel sinkt um 60 Euro!
ソース: deraktionaer.de
0
0
2
0
2千
ETNOWlive's profile picture. Your ultimate destination for business news, economic insights and expert opinions. Rise with India! Rise with ET NOW!
ET NOW
@ETNOWlive
/12/09

#NewsAlert | Zydus Lifesciences partners with Formycon to license and supply a Keytruda biosimilar in the US and Canada #Zydus #Formycon #Biosimilar #Pharma

ETNOWlive's tweet image. #NewsAlert | Zydus Lifesciences partners with Formycon to license and supply a Keytruda biosimilar in the US and Canada #Zydus #Formycon #Biosimilar #Pharma
0
0
5
0
1千
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
/12/16

#Fresenius is the fastest growing #biosimilar company globally. #Formycon $FYB (source: Fresenius)

doepke_michel's tweet image. #Fresenius is the fastest growing #biosimilar company globally. #Formycon $FYB (source: Fresenius)
0
0
5
4
1千
Papamicha007's profile picture. Hier Privat. #Vermögensverwaltung, #Kapitalmarkt, #Aktien insb. aus #Süddeutschland, Musik, #VfB, und was sonst noch Interessant ist 😎 #thinkglobalinvestlocal
Michael Mayer
 @Papamicha007
2023/11/29

Tag3 des #EKF23 #EKF2023 neigt sich dem Ende zu, u.a. #Formycon #MSIndustries #NFON #PWO #Stratec und #Veganz gesehen. Jetzt ist’s gut….. vielen Dank für die Orga, die vielen gute Gespräche und Begegnungen & allen eine gute Heimreise. C u @ #EKF24 👍🏻@DBCashMarket

Papamicha007's tweet image. Tag3 des #EKF23 #EKF2023 neigt sich dem Ende zu, u.a. #Formycon #MSIndustries #NFON #PWO #Stratec und #Veganz gesehen. Jetzt ist’s gut….. vielen Dank für die Orga, die vielen gute Gespräche und Begegnungen & allen eine gute Heimreise. C u @ #EKF24 👍🏻@DBCashMarket
Papamicha007's tweet image. Tag3 des #EKF23 #EKF2023 neigt sich dem Ende zu, u.a. #Formycon #MSIndustries #NFON #PWO #Stratec und #Veganz gesehen. Jetzt ist’s gut….. vielen Dank für die Orga, die vielen gute Gespräche und Begegnungen & allen eine gute Heimreise. C u @ #EKF24 👍🏻@DBCashMarket
1
1
4
0
493
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
2024/05/20

cc $FYB #Formycon

TradeHawk's profile picture. Stock market information. Low volume, high quality. Tweets are not recommendations to buy or sell any security.
TradeHawk
@TradeHawk
2024/05/20

$BIIB $REGN Biogen and Samsung Bioepis get FDA approval of Opuviz, a biosimilar to Regenerons Eylea. accessdata.fda.gov/drugsatfda_doc…

0
0
1
0
3千
0
0
0
0
777
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
2025/01/07

$FYB #Formycon 52-week high. German based #biosimilar specialist - #Stelara biosimilar should be available in the US soon. #Keytruda asset really interesting, $MRK generated sales of $25B with the drug in 2023. Three undisclosed immunology projects on top. $BAYN $JNJ

doepke_michel's tweet image. $FYB #Formycon 52-week high. German based #biosimilar specialist - #Stelara biosimilar should be available in the US soon. #Keytruda asset really interesting, $MRK generated sales of $25B with the drug in 2023. Three undisclosed immunology projects on top. $BAYN $JNJ
1
0
4
1
2千
wiwo's profile picture. Weiterdenken. Weiterkommen. • https://t.co/sT6cxnrOWf
WirtschaftsWoche
@wiwo
2024/06/29

Erst #Hexal, dann #Biontech, jetzt #Formycon: Andreas und Thomas Strüngmann haben ein Händchen für starke Medikamente und gute Geschäfte. In den #USA haben sie nun wieder einen großen Erfolg gelandet. wiwo.de/unternehmen/in…

0
0
1
0
1千
Papamicha007's profile picture. Hier Privat. #Vermögensverwaltung, #Kapitalmarkt, #Aktien insb. aus #Süddeutschland, Musik, #VfB, und was sonst noch Interessant ist 😎 #thinkglobalinvestlocal
Michael Mayer
 @Papamicha007
2025/02/17

Heute dicker Schlag in die FreXXe bei #Formycon, -33% aktuell, heute 17 Uhr dann #ConferenceCall dazu - eqs-news.com/de/news/corpor…

0
0
2
0
334
Papamicha007's profile picture. Hier Privat. #Vermögensverwaltung, #Kapitalmarkt, #Aktien insb. aus #Süddeutschland, Musik, #VfB, und was sonst noch Interessant ist 😎 #thinkglobalinvestlocal
Michael Mayer
 @Papamicha007
2023/09/29

Next Step -> #Formycon und #FreseniusKabi geben Annahme des Zulassungsantrags durch die Europäische Arzneimittel-Agentur (#EMA) für #FYB202, einen #Ustekinumab Biosimilar-Kandidaten, bekannt -> eqs-news.com/de/news/corpor…

0
0
1
0
174
mwbresearch's profile picture. Professional equity research on mostly German stocks. Read and subscribe for free on the ResearchHub. We are MiFID 2 compliant. https://t.co/ZKVqRoaHPu
mwb research
 @mwbresearch
/03/05

#Formycon💊 📉Preliminary FY2025 results miss guidance with revenue ~€45m, driven by slow uptake of ustekinumab biosimilar FYB202 🔍Limited US listings hinder growth; potential non-cash impairment looms 🔽PT cut to €40 ✅BUY 👉research-hub.de $FMY1 #Biosimilars #Pharma

mwbresearch's tweet image. #Formycon💊 📉Preliminary FY2025 results miss guidance with revenue ~€45m, driven by slow uptake of ustekinumab biosimilar FYB202 🔍Limited US listings hinder growth; potential non-cash impairment looms 🔽PT cut to €40 ✅BUY 👉research-hub.de $FMY1 #Biosimilars #Pharma
0
0
3
0
150
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
/02/05

$FYB #Formycon FYB206 – #Keytruda #Biosimilar candidate Top Line Data expected in Q1/2026. $MRK deraktionaer.de/artikel/pharma…

doepke_michel's tweet image. $FYB #Formycon FYB206 – #Keytruda #Biosimilar candidate Top Line Data expected in Q1/2026. $MRK deraktionaer.de/artikel/pharma…
0
0
9
0
1千
makum727272's profile picture. 📈 Früher Investor in $TSLA, $NVDA, $PLTR & $HIMS | 🔎 Analyse von Tenbagger & 100x Investments | ❌ Keine Anlageempfehlung | Folge mir jetzt & aktivier die 🔔
Max Rahn 💯
 @makum727272
/01/13

🚨 Insider-Verkauf bei Formycon AG gemeldet. Options-Flow wird erwartet. Strategischer Kontext: Allmählicher Einstieg. Jetzt die Gelegenheit im deutschen Markt nutzen. #Formycon #FYB #Deutschland 👇

makum727272's tweet image. 🚨 Insider-Verkauf bei Formycon AG gemeldet. Options-Flow wird erwartet. Strategischer Kontext: Allmählicher Einstieg. Jetzt die Gelegenheit im deutschen Markt nutzen. #Formycon #FYB #Deutschland 👇
0
0
0
0
34
chaperonycon's profile picture. Biotech investor with a strong focus on biosimilars and biobetters. Innovation needs the pressure from patent cliffs.
SpeedyGonzalesi
 @chaperonycon
/01/10

„Regional Court Munich grants PI to Regeneron against generics in Eylea case.“ eylea ip formulation prevents biosim competition in most of europe. settlement agreement needed. #formycon #biosimilars #eylea juve-patent.com/cases/regional…

chaperonycon's tweet card. Regeneron and Bayer have successfully defended their ophthalmic drug Eylea at Munich Regional Court as judges grant PI against generics.
Regional Court Munich grants PI to Regeneron against generics in Eylea case
ソース: juve-patent.com
0
0
0
0
56
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
/12/16

#Fresenius is the fastest growing #biosimilar company globally. #Formycon $FYB (source: Fresenius)

doepke_michel's tweet image. #Fresenius is the fastest growing #biosimilar company globally. #Formycon $FYB (source: Fresenius)
0
0
5
4
1千
StoxBox_'s profile picture. Your go-to value broker dedicated to your investment success. Follow us for daily market updates, and insights into finance, economics, and the stock market.
StoxBox
 @StoxBox_
/12/10

Zydus Lifesciences and Formycon sign a licensing deal for FYB206, a biosimilar to Keytruda, targeting the US and Canada. BLA filing expected soon as global acceptance for pembrolizumab continues to grow. #Zydus #Formycon #Biosimilar #PharmaNews #Keytruda #USMarket #CanadaMarket

1
0
0
0
48
CapitalInsight3's profile picture. 📊 Breaking corporate & market news | IPOs · FII/DII · Corporate Actions| Daily updates | India's fastest finance feed Invest Smart. Build Strong
CapitalInsight
@CapitalInsight3
/12/09

Zydus Lifesciences enters exclusive partnership with Formycon for Biosimilar Keytruda ✅ Partnership covers licensing & supply of the Keytruda biosimilar ✅ Target markets: US & Canada #Zydus #Formycon #Biotech #PharmaNews #Keytruda #Healthcare #Markets

0
0
1
0
58
CNBCTV18News's profile picture. Follow business news with India's Leading Business News Channel, CNBC-TV18. For more updates, follow @CNBCTV18Live. YouTube: https://t.co/8QufJyJ9c9
CNBC-TV18
@CNBCTV18News
/12/09

#Zydus Life unit partners with #Formycon to supply immunotherapy drug Keytruda biosimilar in US, Canada #ZydusLifesciences @jpullokaran buff.ly/oohK5is

CNBCTV18News's tweet image. #Zydus Life unit partners with #Formycon to supply immunotherapy drug Keytruda biosimilar in US, Canada #ZydusLifesciences @jpullokaran buff.ly/oohK5is
2
3
7
1
2千
CrweWorld's profile picture.
Crwe World
 @CrweWorld
/12/09

Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda (Pembrolizumab), in the U.S. and Canada #Formycon, #Zydus crweworld.com/article/news-p…

0
0
0
0
34
ZydusUniverse's profile picture. Zydus is one of India's leading healthcare companies & a global healthcare provider. Follow us to know more about us. https://t.co/FxBjn4Qvf1
Zydus Lifesciences Ltd.
@ZydusUniverse
/12/09

Zydus and @formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda®️ (Pembrolizumab), in US and Canada. #Zydus #ZydusGroup #Formycon #Partnership

ZydusUniverse's tweet image. Zydus and @formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda®️ (Pembrolizumab), in US and Canada. #Zydus #ZydusGroup #Formycon #Partnership
ZydusUniverse's tweet image. Zydus and @formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda®️ (Pembrolizumab), in US and Canada. #Zydus #ZydusGroup #Formycon #Partnership
0
0
0
0
223
ETNOWlive's profile picture. Your ultimate destination for business news, economic insights and expert opinions. Rise with India! Rise with ET NOW!
ET NOW
@ETNOWlive
/12/09

#NewsAlert | Zydus Lifesciences partners with Formycon to license and supply a Keytruda biosimilar in the US and Canada #Zydus #Formycon #Biosimilar #Pharma

ETNOWlive's tweet image. #NewsAlert | Zydus Lifesciences partners with Formycon to license and supply a Keytruda biosimilar in the US and Canada #Zydus #Formycon #Biosimilar #Pharma
0
0
5
0
1千
mwbresearch's profile picture. Professional equity research on mostly German stocks. Read and subscribe for free on the ResearchHub. We are MiFID 2 compliant. https://t.co/ZKVqRoaHPu
mwb research
 @mwbresearch
/12/02

#Formycon 💊 📈 Operational stability showcased 🔍 Progress on biosimilars FYB201, FYB202, FYB206; partnering deal expected by year-end 🌱 FYB208 expands into immunology ✅ BUY 👉 Join our Roundtable on Dec 9 for insights: research-hub.de/events/registr… #Biosimilars #Pharma

mwbresearch's tweet image. #Formycon 💊 📈 Operational stability showcased 🔍 Progress on biosimilars FYB201, FYB202, FYB206; partnering deal expected by year-end 🌱 FYB208 expands into immunology ✅ BUY 👉 Join our Roundtable on Dec 9 for insights: research-hub.de/events/registr… #Biosimilars #Pharma
0
0
1
0
120
Papamicha007's profile picture. Hier Privat. #Vermögensverwaltung, #Kapitalmarkt, #Aktien insb. aus #Süddeutschland, Musik, #VfB, und was sonst noch Interessant ist 😎 #thinkglobalinvestlocal
Michael Mayer
 @Papamicha007
2023/11/29

Tag3 des #EKF23 #EKF2023 neigt sich dem Ende zu, u.a. #Formycon #MSIndustries #NFON #PWO #Stratec und #Veganz gesehen. Jetzt ist’s gut….. vielen Dank für die Orga, die vielen gute Gespräche und Begegnungen & allen eine gute Heimreise. C u @ #EKF24 👍🏻@DBCashMarket

Papamicha007's tweet image. Tag3 des #EKF23 #EKF2023 neigt sich dem Ende zu, u.a. #Formycon #MSIndustries #NFON #PWO #Stratec und #Veganz gesehen. Jetzt ist’s gut….. vielen Dank für die Orga, die vielen gute Gespräche und Begegnungen & allen eine gute Heimreise. C u @ #EKF24 👍🏻@DBCashMarket
Papamicha007's tweet image. Tag3 des #EKF23 #EKF2023 neigt sich dem Ende zu, u.a. #Formycon #MSIndustries #NFON #PWO #Stratec und #Veganz gesehen. Jetzt ist’s gut….. vielen Dank für die Orga, die vielen gute Gespräche und Begegnungen & allen eine gute Heimreise. C u @ #EKF24 👍🏻@DBCashMarket
1
1
4
0
493
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
2025/01/07

$FYB #Formycon 52-week high. German based #biosimilar specialist - #Stelara biosimilar should be available in the US soon. #Keytruda asset really interesting, $MRK generated sales of $25B with the drug in 2023. Three undisclosed immunology projects on top. $BAYN $JNJ

doepke_michel's tweet image. $FYB #Formycon 52-week high. German based #biosimilar specialist - #Stelara biosimilar should be available in the US soon. #Keytruda asset really interesting, $MRK generated sales of $25B with the drug in 2023. Three undisclosed immunology projects on top. $BAYN $JNJ
1
0
4
1
2千
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
/02/05

$FYB #Formycon FYB206 – #Keytruda #Biosimilar candidate Top Line Data expected in Q1/2026. $MRK deraktionaer.de/artikel/pharma…

doepke_michel's tweet image. $FYB #Formycon FYB206 – #Keytruda #Biosimilar candidate Top Line Data expected in Q1/2026. $MRK deraktionaer.de/artikel/pharma…
0
0
9
0
1千
Papamicha007's profile picture. Hier Privat. #Vermögensverwaltung, #Kapitalmarkt, #Aktien insb. aus #Süddeutschland, Musik, #VfB, und was sonst noch Interessant ist 😎 #thinkglobalinvestlocal
Michael Mayer
 @Papamicha007
2023/10/10

Übergeordneter Trend ist noch intakt und ändert sich erst >65. Ich persönlich finde das Thema #Biosimilar sehr spannend. #Formycon hat eine spannende #Pipeline, ist durch #Investoren gut gebacked und hat eine international attraktive Bewertung. We will see. #NoAdvice #MYODD

Papamicha007's tweet image. Übergeordneter Trend ist noch intakt und ändert sich erst >65. Ich persönlich finde das Thema #Biosimilar sehr spannend. #Formycon hat eine spannende #Pipeline, ist durch #Investoren gut gebacked und hat eine international attraktive Bewertung. We will see. #NoAdvice #MYODD
1
0
1
0
97
mwbresearch's profile picture. Professional equity research on mostly German stocks. Read and subscribe for free on the ResearchHub. We are MiFID 2 compliant. https://t.co/ZKVqRoaHPu
mwb research
 @mwbresearch
/10/02

#Formycon 💉 📑 Settlement with Regeneron secures U.S. entry for FYB203 (aflibercept/Eylea biosimilar) 📆 Launch expected Q4 2026 ⚙️ Expands late-stage pipeline visibility ✅ BUY 👉 research-hub.de $FYB

mwbresearch's tweet image. #Formycon 💉 📑 Settlement with Regeneron secures U.S. entry for FYB203 (aflibercept/Eylea biosimilar) 📆 Launch expected Q4 2026 ⚙️ Expands late-stage pipeline visibility ✅ BUY 👉 research-hub.de $FYB
0
0
0
0
142
mwbresearch's profile picture. Professional equity research on mostly German stocks. Read and subscribe for free on the ResearchHub. We are MiFID 2 compliant. https://t.co/ZKVqRoaHPu
mwb research
 @mwbresearch
2025/03/28

#Formycon FY results were severely impacted by impairments. 2025 revenues are expected to be stable yoy, but competitive pressure in the U.S. weighs on the commercial pipeline. BUY with lower PT. research-hub.de

mwbresearch's tweet image. #Formycon FY results were severely impacted by impairments. 2025 revenues are expected to be stable yoy, but competitive pressure in the U.S. weighs on the commercial pipeline. BUY with lower PT. research-hub.de
0
0
1
0
69
formycon's profile picture. Formycon is a leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars.
Formycon
 @formycon
2023/06/06

On Thursday June 08, 2023 at 14:30 (CET) you can join us live via video webcast when Dr. Stefan Glombitza (CEO) and Enno Spillner (CFO) present Formycon AG at the Jefferies Global Healthcare Conference 2023 formycon.com/en/blog/press-… #Formycon #JefferiesHealthcare #Biosimilars

formycon's tweet image. On Thursday June 08, 2023 at 14:30 (CET) you can join us live via video webcast when Dr. Stefan Glombitza (CEO) and Enno Spillner (CFO) present Formycon AG at the Jefferies Global Healthcare Conference 2023 formycon.com/en/blog/press-… #Formycon #JefferiesHealthcare #Biosimilars
0
0
5
0
124
WinterLars's profile picture. Fondsmanager Salus Alpha & Manager des Wikifolios https://t.co/VZWbB0GAVR Stv. Chefredakteur @BoerseOnline a.D. & Redaktionsleiter @EuroamSonntag a.D. Hier privat
Lars Winter
 @WinterLars
2023/01/04

#Formycon robbt sich langsam wieder ans Allzeithoch bei 91,70 € ran. Obs heute noch geknackt wird? Ich glaube ja!

WinterLars's tweet image. #Formycon robbt sich langsam wieder ans Allzeithoch bei 91,70 € ran. Obs heute noch geknackt wird? Ich glaube ja!
1
0
7
0
1千
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
/12/16

#Fresenius is the fastest growing #biosimilar company globally. #Formycon $FYB (source: Fresenius)

doepke_michel's tweet image. #Fresenius is the fastest growing #biosimilar company globally. #Formycon $FYB (source: Fresenius)
0
0
5
4
1千
mwbresearch's profile picture. Professional equity research on mostly German stocks. Read and subscribe for free on the ResearchHub. We are MiFID 2 compliant. https://t.co/ZKVqRoaHPu
mwb research
 @mwbresearch
2024/12/06

#Formycon AG's Formycon AG’s inclusion in the SDAX index, effective December 23, 2024, marks a significant milestone in the company’s growth trajectory. BUY. research-hub.de

mwbresearch's tweet image. #Formycon AG's Formycon AG’s inclusion in the SDAX index, effective December 23, 2024, marks a significant milestone in the company’s growth trajectory. BUY. research-hub.de
0
0
2
1
95
4investors's profile picture. Impressum: https://t.co/DOAdqJ8Vyp - Interviews + Berichte, Schwerpunkt deutscher Aktienmarkt - Hier zwitschern Michael Barck und unser Newsbot.
4investors.de
 @4investors
2024/11/28

Formycon startet in eine neue und bedeutende Unternehmensphase ... 4investors.de/nachrichten/bo… #formycon #aktien

4investors's tweet image. Formycon startet in eine neue und bedeutende Unternehmensphase ... 4investors.de/nachrichten/bo… #formycon #aktien
0
0
0
1
215
ZydusUniverse's profile picture. Zydus is one of India's leading healthcare companies & a global healthcare provider. Follow us to know more about us. https://t.co/FxBjn4Qvf1
Zydus Lifesciences Ltd.
@ZydusUniverse
/12/09

Zydus and @formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda®️ (Pembrolizumab), in US and Canada. #Zydus #ZydusGroup #Formycon #Partnership

ZydusUniverse's tweet image. Zydus and @formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda®️ (Pembrolizumab), in US and Canada. #Zydus #ZydusGroup #Formycon #Partnership
ZydusUniverse's tweet image. Zydus and @formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda®️ (Pembrolizumab), in US and Canada. #Zydus #ZydusGroup #Formycon #Partnership
0
0
0
0
223
ETNOWlive's profile picture. Your ultimate destination for business news, economic insights and expert opinions. Rise with India! Rise with ET NOW!
ET NOW
@ETNOWlive
/12/09

#NewsAlert | Zydus Lifesciences partners with Formycon to license and supply a Keytruda biosimilar in the US and Canada #Zydus #Formycon #Biosimilar #Pharma

ETNOWlive's tweet image. #NewsAlert | Zydus Lifesciences partners with Formycon to license and supply a Keytruda biosimilar in the US and Canada #Zydus #Formycon #Biosimilar #Pharma
0
0
5
0
1千
mwbresearch's profile picture. Professional equity research on mostly German stocks. Read and subscribe for free on the ResearchHub. We are MiFID 2 compliant. https://t.co/ZKVqRoaHPu
mwb research
 @mwbresearch
/11/13

#Formycon 💊 📉 9M revenues at €19.5m; Q3 contributes €10.5m after a slow start in H1 2025 📈 Q3 EBITDA improves to €-3.5m vs H1 €-17.9m 🔍 FYB202 ramping up; FYB201 awaits Sandoz US relaunch in 2026 ✅ BUY | PT €48.00 👉 research-hub.de $FMYN #Biotech

mwbresearch's tweet image. #Formycon 💊 📉 9M revenues at €19.5m; Q3 contributes €10.5m after a slow start in H1 2025 📈 Q3 EBITDA improves to €-3.5m vs H1 €-17.9m 🔍 FYB202 ramping up; FYB201 awaits Sandoz US relaunch in 2026 ✅ BUY | PT €48.00 👉 research-hub.de $FMYN #Biotech
0
0
0
0
99
CNBCTV18News's profile picture. Follow business news with India's Leading Business News Channel, CNBC-TV18. For more updates, follow @CNBCTV18Live. YouTube: https://t.co/8QufJyJ9c9
CNBC-TV18
@CNBCTV18News
/12/09

#Zydus Life unit partners with #Formycon to supply immunotherapy drug Keytruda biosimilar in US, Canada #ZydusLifesciences @jpullokaran buff.ly/oohK5is

CNBCTV18News's tweet image. #Zydus Life unit partners with #Formycon to supply immunotherapy drug Keytruda biosimilar in US, Canada #ZydusLifesciences @jpullokaran buff.ly/oohK5is
2
3
7
1
2千
ferele5447's profile picture. #StanWeinstein 📈 Las compras siempre con Stop 🛑 #Efpa 19187 #Timing @CBBreogan 🏀 #Ev ⚡#Tesla 🚙 #ModelY 🔋 #VoyaGanar al #MielomaMultiple #yomecuro
ferele5447
 @ferele5447
2023/01/06

$FYB 🔬🇩🇪 #Formycon La biotecnológica alemana especializada en medicamentos biosimilares rompe con un 207% de volumen, ya muy fuerte, esta semana volvió el volumen, las que no vuelven son las MFs, se trata de un valor muy estrecho, no llega al millón de euros de negociación.

ferele5447's tweet image. $FYB 🔬🇩🇪 #Formycon La biotecnológica alemana especializada en medicamentos biosimilares rompe con un 207% de volumen, ya muy fuerte, esta semana volvió el volumen, las que no vuelven son las MFs, se trata de un valor muy estrecho, no llega al millón de euros de negociación.
ferele5447's tweet image. $FYB 🔬🇩🇪 #Formycon La biotecnológica alemana especializada en medicamentos biosimilares rompe con un 207% de volumen, ya muy fuerte, esta semana volvió el volumen, las que no vuelven son las MFs, se trata de un valor muy estrecho, no llega al millón de euros de negociación.
0
1
9
0
591

Something went wrong.


Something went wrong.


United States Trends